D
Danimer Scientific
Producer of biopolymers manufacturer of PHA bioplastics from renewable, natural resources
About Danimer Scientific
Danimer Scientific, a biopolymer manufacturer based in Bainbridge, Georgia, was established in 2004 to address the environmental impact of traditional plastics. The company's primary focus is the production of biodegradable and compostable alternatives to petroleum-based plastics. A significant milestone in its early history was the 2007 acquisition of polyhydroxyalkanoate (PHA) intellectual property from Procter & Gamble. This acquisition included the technology for what would become their signature product, Nodax® PHA. The company, formerly known as Meredian Holdings Group Inc., rebranded as Danimer Scientific in October 2016. Stephen E. Croskrey, a graduate of the US Military Academy and the Kellogg School of Management, has been a key figure in the company's leadership, serving as CEO from 2016 until his retirement in 2024. The company went public in December 2020 through a merger with a special purpose acquisition company (SPAC), Live Oak Acquisition Corp.
The core of Danimer Scientific's business is the production of PHA, a biopolymer created through a fermentation process where microorganisms consume plant-based oils, like canola oil, and produce PHA. This material, sold under the brand name Nodax®, is certified as biodegradable in various environments, including soil, freshwater, and marine settings, and is also compostable. Nodax® is designed to be a direct replacement for conventional plastics in a wide range of applications, such as drinking straws, cutlery, food packaging, films, and coatings. The company serves major consumer brands and plastic converters looking to shift to more sustainable materials without significant changes to their manufacturing processes. Revenue is generated primarily from the sale of these biopolymer resins. A secondary revenue stream comes from offering specialty toll manufacturing and compounding services, where other companies can utilize Danimer's facilities and expertise to produce products based on their own formulations.
Despite its technological advancements and partnerships with major brands like PepsiCo and Nestlé, Danimer has faced considerable financial difficulties. The company has reported significant net losses and, in March 2025, filed for Chapter 11 bankruptcy protection after experiencing a critical cash shortage and the loss of a key customer contract.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2004
- Headquarters
- Bainbridge, United States
- Listing
- IPO 2020
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
United Soybean Board
Series A1 investor entered at this stage
- ACAdvantage Capital
Series B and later2 investors entered at this stage
Advantage Capital
Mountain Ridge Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Danimer Scientific on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Danimer Scientific on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
